Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient
Cellular Oncology · 2026
DOI: 10.1007/s13402-026-01172-y ↗Kurz gefasst
Fallbericht in der Zeitschrift Cellular Oncology, 2026. Verfasst von Xinyu Gao und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Genetic Engineering, Human Phenome Institute, Fudan University, Shanghai, 200438, China. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Organoids, Precision Medicine, Neuroendocrine Tumors. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Genetic Engineering, Human Phenome Institute, Fudan University, Shanghai, 200438, China.
- The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, School of Basic Medical Sciences, Institute of Organoid Research, The First Affiliated Hospital, Nanchang University, Nanchang,…
- Grit Biotechnology Ltd, Building No. 24, 388 Sheng Rong Road, Pudong District, Shanghai, 201210, China.
- Z Lab, bioGenous BIOTECH, Shanghai, 200438, China.
- Department of Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200430, China.
- Department of Chemical Engineering and Materials Science, University of Southern California, 3710 McClintock Ave, Los Angeles, CA, 90089, USA.
Zitieren
APA
Gao, X., Liu, Z., Xu, Z., Liu, K., Zhang, Y., Yu, J., Wang, X., Cheng, X., Ni, C., Wang, P., Liu, Y., Hong, X., Sun, J., & Zhao, B. (2026). Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. Cellular Oncology. https://doi.org/10.1007/s13402-026-01172-y
Vancouver
Gao X, Liu Z, Xu Z, Liu K, Zhang Y, Yu J, et al. Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. Cellular Oncology. 2026. doi:10.1007/s13402-026-01172-y
BibTeX
@article{Gao2026,
author = {Gao, Xinyu and Liu, Zhenjiang and Xu, Zhaoting and Liu, Ke and Zhang, Yiming and Yu, Jing and Wang, Xu and Cheng, Xinghua and Ni, Chao and Wang, Pin and Liu, Yarong and Hong, Xinfang and Sun, Jingwei and Zhao, Bing},
title = {Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient},
journal = {Cellular Oncology},
year = {2026},
doi = {10.1007/s13402-026-01172-y}
}
EUVIMED